The Exchange had sought clarification from Dcm Shriram Industries Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Consolidated Financial Results not submitted The response of the Company is enclosed.
DCMSRIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE sought clarification from DCM Shriram Industries on why consolidated financial results were not submitted for the quarter ended December 31, 2025. The company explained that a composite Scheme of Arrangement (demerger) approved by NCLT became effective on December 17, 2025 (with retrospective effect from April 1, 2023), under which two subsidiaries — DCM Shriram Fine Chemicals Ltd and DCM Shriram International Ltd — ceased to be subsidiaries, and its associate DCM Hyundai Ltd moved to one of the resulting companies. As a result, the company no longer has any subsidiary, associate, or joint venture as of the reporting date, making consolidated results not applicable. Standalone financial results for Q3 FY26 have been submitted instead.
This is a routine clarification, not a penalty or adverse action. The structural change reflects a completed corporate restructuring that simplifies the group — shareholders should note the company now operates as a standalone entity without subsidiaries, which changes how its financials will be reported going forward.